Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00783952 · ClinicalTrials.gov registry record · NA

Validation of Mixed Venous Blood Oxygen Saturation Obtained With a Novel Mathematical Equation

A NA study, sponsored by Massachusetts General Hospital.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT00783952: Clinical Trial NA study, sponsored by Massachusetts General Hospital.

NCT00783952 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00783952, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

The purpose of this study is to test a new way to measure the oxygen level in the mixed venous blood system (the system that carries blood collected from all over the body to the heart), which is a very important monitoring tool for the overall oxygen delivery to all our tissues. This new way measures the oxygen level in the mixed venous blood from outside the body, instead of measuring from the inside through a catheter (a thin, flexible plastic tube) that is placed by breaking the skin.

Primary Outcome

Four sensors of the 'Cerebral/Somatic Tissue Oximeter' device will be placed on subject's both sides of the forehead, palm and calf area. Simultaneously, blood samples will be drawn from the pulmonary artery catheter and arterial line for blood gas analyses. The values obtained from the device measurements will be used in a new equation to calculate the mixed venous oxygen saturation. The calculated value will be compared to the real value from the blood gas analysis for accuracy.

Interventions

  • DEVICE Cerebral/Somatic Tissue Oximeter device
  • DEVICE Pulmonary artery catheter

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2008-11
Est. Completion 2013-01
Phase NA
Massachusetts General Hospital

2,032 total trials

Why NCT00783952 stopped before completion

NCT00783952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Cerebral/Somatic Tissue Oximeter device is the first listed.

NCT00783952 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00783952 about?

NCT00783952 is a clinical study titled "Validation of Mixed Venous Blood Oxygen Saturation Obtained With a Novel Mathematical Equation". The purpose of this study is to test a new way to measure the oxygen level in the mixed venous blood system (the system that carries blood collected from all over the body to the heart), which is a very important monitoring tool for the overall oxygen delivery to all our tissues. This new way measur...

What is the current status of trial NCT00783952?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2008-11. Estimated completion is 2013-01.

What interventions are being tested in trial NCT00783952?

The interventions under investigation include: Cerebral/Somatic Tissue Oximeter device (DEVICE), Pulmonary artery catheter (DEVICE).

Who is sponsoring clinical trial NCT00783952?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00783952's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00783952, the US trial registry maintained by the National Library of Medicine. NCT00783952 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.